In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Proligo LLC

Division of Merck KGaA
www.proligo.com

Latest From Proligo LLC

Biopharma: Beyond the First Product

For biopharma, launching first products, and especially sudden profitability, doesn't necessarily predict which companies will succeed. Instead, an examination of stock market success shows the need to bring a succession of drugs, or at least additional indications, into clinical trials-mostly through aggressive deal-making.
BioPharmaceutical Strategy

Recent Dealmaking (06/2004)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merck KGaA
  • Senior Management
  • Klaus F Puell, Pres. & CEO
    Alecia Settle, Dir., Bus. Dev.
  • Contact Info
  • Proligo LLC
    Phone: (303) 998-0801
    2995 Wilderness Place
    Boulder, CO 80301
    USA
UsernamePublicRestriction

Register